Latest News

In a recent Practice Academy webinar session, Nina Kottler, MD, MS, FSIIM, FAIM, discussed challenges with narrow AI applications, the continued emergence of foundation models and a potential trajectory with AI that may facilitate a combination of opportunistic screening and prognostic risk assessment.

In a recent Practice Academy webinar session, Seena Dehkharghani, MD, FAHA, and Raza Mushtaq, MD, discussed the challenge of burgeoning worklist volume amid the ongoing radiologist shortage and the emergence of AI advances with enterprise imaging.

The cmAngio 2.0 AI-enabled software reportedly offers new capabilities for quantitative measurement of breast arterial calcification (BAC) as well as age-based contextualization based on mammography assessment.

New research revealed that risk-stratified MRI surveillance in patients with cirrhosis led to over a 10 percent increase in early detection and over a 44 percent decrease in surveillance exams in comparison to reported results with semiannual ultrasound monitoring.

While maintenance of certification requires participation in peer review, a collegial ethos enables us to provide assessment of another radiologist’s work without crossing the line into odious expert witness cash grabs.

Catch up on the latest contrast-enhanced mammography research, CT insights, MRI studies and FDA approvals in PET imaging with our Weekly Scan.

Recent positron emission tomography (PET) studies with florquinitau F 18 injection (Tauklarify) demonstrated inter-reader agreement ranging between 86 to 92 percent in evaluating patients for Alzheimer’s disease.

The high-resolution temporal and spatial imaging with photon-counting CT bolster our understanding of the connections between anatomy and function in structural heart imaging.

Use of the CARE Multi-Triage CT Body software will be eligible for a New Technology Add-on Payment (NTAP) from CMS starting on October 1, 2026 for inpatients in Medicare fee for service plans.

In a recent episode of our “Molecular Imaging in Focus” series, Martin Pomper, MD, PhD, discussed the origin of PSMA PET, shared his perspective on non-PSMA targets in prostate cancer and offered his thoughts on the potential promise of emerging theranostics.

The VueJect ultrasound contrast delivery system, which is geared toward cardiac ultrasound imaging, also gained Health Canada authorization.

Catch up on the latest blogs from Filippo Cademartiri, MD, PhD, who discusses topics ranging from CCTA scan acquisition and photon-counting CT to artificial intelligence and assessment of current plaque as a biomarker for evaluating MACE risk.

In comparison to standard readout-segmented echo-planar imaging, the combination of deep learning reconstruction and multi-shot diffusion-weighted imaging (DWI) offered significantly higher SNR, CNR and lesion contrast with a greater than a two-minute reduction in scan time.